TRIOAR
Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
TRIOAR
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.trioar.co.kr
Status:
Active
Contact:
+82 042-931-3911
Email Addresses:
[email protected]
Total Funding:
320 M KRW
Technology used in webpage:
Domain Not Resolving Java EE LG U Plus
Similar Organizations
AL Biotech
AL Biotech is a biotechnology company that develops biopharmaceutical drugs.
Albcura
Albcura provides biotechnology research on recombinant proteins and aseptic processes.
Gene Techno Science
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.
Suzhou Fushilai Pharmaceutical Co., Ltd.
Suzhou Fushilai Pharmaceutical is a manufacturer of biopharmaceutical products.
Investors List
KB Investment
KB Investment investment in Seed Round - Trioar
IMM Investment
IMM Investment investment in Seed Round - Trioar
Bokwang Investment
Bokwang Investment investment in Seed Round - Trioar
JL Partners
JL Partners investment in Angel Round - Trioar
Official Site Inspections
http://www.trioar.co.kr Semrush global rank: 5.58 M Semrush visits lastest month: 1.29 K
- Host name: 211.47.74.48
- IP address: 211.47.74.48
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Trioar"
TRIOAR
Shaping a better, healthier future for humanity We are developing novel platform technologies for next-generation antibody-based therapeutics such as ADC (Antibody-Drug Conjugates) and โฆSee details»
Trioar - Crunchbase Company Profile & Funding
Headquarters Regions Asia-Pacific (APAC) Founded Date 2021 Operating โฆSee details»
TriOar Inc. โ K-Bio Bridge
TriOar Inc. is a biotech company focusing on developing next-generation antibody-based therapeutics including ADC (Antibody Drug Conjugates) and โฆSee details»
Trioar 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for โฆSee details»
TriOar Inc. Company Profile | Daejeon, Daejeon, Republic Of Korea ...
Find company research, competitor information, contact details & financial data for TriOar Inc. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet.See details»
Trioar - Products, Competitors, Financials, Employees, โฆ
Trioar is a biotechnology company focused on the development of antibody-based platform technologies in the pharmaceutical industry. The company researches next-generation โฆSee details»
TriOar - VentureRadar
The TriOar platform sequentially targets cancer lesions and quickly and accurately reaches tumor cells. Our platform activates an anti-cancer effect only at the target site to enhance drug safety.See details»
TRIOAR - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 30, 2025 TRIOAR is a seed company based in Yuseong District (South Korea), founded in 2021. It operates as a Developer of drugs for the treatment of cancer. TRIOAR has raised an โฆSee details»
BioIN+
Jun 25, 2024 ๊ธฐ์ ์๊ฐ ํธ๋ฆฌ์ค์ด๋ ๊ณ ์ ์ ๊ธฐ๋ฐ ๊ธฐ์ ์ ๋ณด์ ํ ์ ์ฝ ๊ฐ๋ฐ ๊ธฐ์ ์ ๋๋ค. ์ฌ์ ๊ฐ์ ํธ๋ฆฌ์ค์ด๋ ๊ณ ์ ์ ๊ธฐ๋ฐ ๊ธฐ์ ์ ๋ณด์ ํ ์ ์ฝ ๊ฐ๋ฐ ๊ธฐ์ ์ ๋๋ค. ์ฃผ์์ฐํ 2021.01 ํ์ฌ์ค๋ฆฝ โฆSee details»
TRIOAR
์ ๊ท Linker-toxin System์ผ๋ก ์์ธํฌ๋ฅผ ๋น ๋ฅด๊ฒ ์ฌ๋ฉธ์ ๋ํ๋ฉฐ, ์ฝ๋ฌผ์์ ์ฑ๊ณผ ์ฝํจ์ฆ๊ฐ๋ฅผ ์คํํ ์ ์์ต๋๋ค.See details»
Sung Ho Woo๋ - Chief Executive Officer - Trioar Inc. | LinkedIn
CEO at Trioar · ๊ฒฝ๋ ฅ: Trioar Inc. · ํ๋ ฅ: Seoul National University · ์ง์ญ: ๋ํ๋ฏผ๊ตญ · LinkedIn์ 1์ด 96๋ช . LinkedIn์์ Sung Ho Woo๋ ํ๋กํ ์กฐํ, 10์ต ๋ช ์ ํ์์ด ์๋ ์ ๋ฌธ๊ฐ ์ปค๋ฎค๋ํฐ.See details»
Trioar Co. Ltd. (Trioar Co. Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
May 7, 2025 100 ้กนไธ Trioar Co. Ltd. ็ธๅ ณ็่ฝฌๅๅปๅญฆSee details»
TriOar | VentureRadar
TriOar has developed a proprietary therapeutic platform designed to deliver products offering better therapeutic window. Our platform is multi-targetable with coverage that can be โฆSee details»
TRIOAR
At TriOar, we are guided by a vision of ushering in a new era in healthcare - one where patients facing the challenges of cancer can find hope and healing through cutting-edge therapies. Our โฆSee details»
ํธ๋ฆฌ์ค์ด, ์๋ฆฌ์ฆA 120์ต โADC ํ๊ณ๊ทน๋ณต ๊ธฐ์ ๊ฐ๋ฐโ
May 24, 2023 TME ์ฝ๋ฌผ์ ๋ฌ ํ๊ณ ๊ทน๋ณต ReleaDomโข ํ๋ซํผ, ํก์ ํจ์จ์ ๋ฐฉ์ถ ์ ๊ท SIG ๊ธฐ์ ๋ฑ ๋ณด์ ํญ์ฒด-์ฝ๋ฌผ์ ํฉ์ฒด (ADC) ๋ฐ์ด์คํ ํธ๋ฆฌ์ค์ด (TriOar)๋ ์ ํ์ฐ์ ์ฃผ (CPS) ๋ฐํ์ ํตํด โฆSee details»
MYOUNGKI BAEK๋ - Chief Development Officer (CDO) - Trioar
Translational Research/Business Development · ๊ฒฝ๋ ฅ: Trioar · ํ๋ ฅ: Martin-Luther-Universität Halle-Wittenberg · ์ง์ญ: ์์ธ · LinkedIn์ 1์ด 475๋ช . LinkedIn์์ MYOUNGKI BAEK๋ โฆSee details»
KASBP - ๋ฐ์ด์ค ๋ฒค์ฒํ์ฌ ํธ๋ฆฌ์ค์ด_์ฌ์ ๊ฐ๋ฐ, ์ฐ๊ตฌ๊ฐ๋ฐ ๋ถ๋ฌธ ๊ฒฝ๋ ฅ์ง โฆ
๋ฐ์ด์ค ๋ฒค์ฒํ์ฌ ํธ๋ฆฌ์ค์ด_์ฌ์ ๊ฐ๋ฐ, ์ฐ๊ตฌ๊ฐ๋ฐ ๋ถ๋ฌธ ๊ฒฝ๋ ฅ์ง ์ฑ์ฉSee details»
Police have arrested an international drug distribution โฆ
9 hours ago Police have arrested an international drug distribution organization that smuggled methamphetamine into the country by hiding it in a specially designed body lotion โฆSee details»
TRIOAR
TriOar is a biotech company focusing on developing next-generation antibody-based therapeutics with novel platform technologies.See details»
ํธ๋ฆฌ์ค์ด, 120์ต์์ ์๋ฆฌ์ฆ A ํฌ์๋ฅผ ํตํด ADC ํ๊ณ๋ฅผ ๊ทน๋ณตํ๋ โฆ
May 24, 2023 ํญ์ฒด-์ฝ๋ฌผ ์ ํฉ์ฒด(ADC) ๋ฐ์ด์คํ ํฌ ํ์ฌ์ธ ํธ๋ฆฌ์ค์ด(TriOar)๋ ์ต๊ทผ 120์ต์์ ์๋ฆฌ์ฆ A ํฌ์๋ฅผ ์ฑ๊ณต์ ์ผ๋ก ์ ์นํ๋ค๊ณ ๋ฐํํ๋ค. ์ด๋ฒ ํฌ์๋ ์ ํ ์ฐ์ ์ฃผ(CPS) ๋ฐํ์ ํตํด โฆSee details»